Aumolertinib as Neoadjuvant and Adjuvant Therapy for Unresectable Stage IIIA-IVA Non-Small Cell Lung Cancer with EGFR Mutations

被引：0
|
作者：
Shao, F. [1 ]
Zhang, Q. [1 ]
Cheng, W. [1 ]
Liu, N. [1 ]
Fang, H. [1 ]
Fang, S. [1 ]
机构：
[1] Nanjing Chest Hosp, Affiliated Brain Hosp Nanjing Med Univ, Nanjing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Neoadjuvant; Aumolertinib; Unresectable EGFR-mutant;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-26
引用
收藏
页码：S651 / S651
页数：1
相关论文
共 50 条
  • [1] Aumolertinib as adjuvant therapy in postoperative EGFR-mutated non-small cell lung cancer
    Zhang, Q.
    He, C.
    He, T.
    Wang, Y.
    Lv, W.
    Hu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S73 - S73
  • [2] Case Report: Aumolertinib as Neoadjuvant Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer With Activated EGFR Mutation: Case Series
    Shao, Feng
    Zhang, Qiang
    Cheng, Wanwan
    Zeng, Zhaozhun
    Xie, Yuewu
    Fang, Shencun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer
    Watanabe, Shun-ichi
    Nakagawa, Kazuo
    Suzuki, Kenji
    Takamochi, Kazuya
    Ito, Hiroyuki
    Okami, Jiro
    Aokage, Keiju
    Saji, Hisashi
    Yoshioka, Hiroshige
    Zenke, Yoshitaka
    Aoki, Tadashi
    Tsutani, Yasuhiro
    Okada, Morihito
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (12) : 1112 - 1118
  • [4] Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer
    Pisters, KMW
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 23 - 28
  • [5] Adjuvant Aumolertinib in Patients with Completely Resected, Stage IA2-IIIA Non-Small-Cell Lung Cancer with Uncommon EGFR Mutations
    Zhang, Q.
    Ke, L.
    Huang, S.
    Yang, Y.
    He, T.
    Sun, H.
    Wu, Z.
    Zhang, X.
    Lv, W.
    Hu, J.
    Ye, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S555 - S556
  • [6] HRQoL with Adjuvant Aumolertinib in Patients with Resected Stage IB-IIIA EGFR Mutant Non Small Cell Lung Cancer
    Hu, W.
    Mao, Z.
    Cheng, N.
    Huang, J.
    Tang, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S563 - S564
  • [7] Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial
    Bian, Dongliang
    Ji, Shuyu
    Liu, Yue
    Huang, Zhida
    Jiang, Lei
    Liu, Ming
    Bao, Xiao
    Yang, Jie
    Zhou, Yirui
    Hu, Junjie
    Sun, Liangdong
    Zheng, Yingzhi
    Huang, Jie
    Liu, Jing
    Zhu, Xinsheng
    Zhang, Jing
    Zhang, Lele
    Liu, Xiaogang
    He, Wenxin
    Xie, Dong
    Zhu, Yuming
    Wu, Chunyan
    Zhao, Deping
    Duan, Liang
    Jiang, Gening
    Zhang, Peng
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [8] Neoadjuvant and adjuvant therapy of non-small cell lung cancer
    Rajdev, L
    Keller, SM
    SURGICAL ONCOLOGY-OXFORD, 2002, 11 (04): : 243 - 253
  • [9] Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer
    Chuang, Jody C.
    Liang, Ying
    Wakelee, Heather A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 31 - +
  • [10] Adjuvant and neoadjuvant therapy in non-small cell lung cancer
    Belani, CP
    SEMINARS IN ONCOLOGY, 2005, 32 (02) : S9 - S15
12345